Comparing Abilify vs Caplyta
Abilify (aripiprazole) | Caplyta (lumateperone) |
|
---|
Abilify (aripiprazole) | Caplyta (lumateperone) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Abilify is an antipsychotic used in the treatment of schizophrenia and several other disorders. Abilify is less likely than some other antipsychotics to cause weight gain. Prescribed for Bipolar... View more |
Prescription only
Caplyta is an atypical antipsychotic that may be used to treat adults with schizophrenia. Sedation is the most common side effect and it should not be used in people with moderate to severe liver... View more |
Related suggestions Bipolar Disorder
Schizophrenia
|
|||||||||||||||
More about Abilify (aripiprazole) | More about Caplyta (lumateperone) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Abilify has an average rating of 6.1 out of 10 from a total of 1182 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 34% reported a negative effect. |
Caplyta has an average rating of 6.5 out of 10 from a total of 173 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 31% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Abilify prices |
View all Caplyta prices |
||||||||||||||||
Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other aripiprazole brands include: Abilify Asimtufii, Abilify Maintena, Abilify MyCite, Aristada, Aristada Initio, Opipza |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
146 hours |
18 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 723 drugs are known to interact with Abilify:
|
A total of 598 drugs are known to interact with Caplyta:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
November 15, 2002 |
December 20, 2019 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.